INS and Hyperglycemia: Several preclinical models have emerged to study GDM, including models of diet-induced maternal hyperglycemia, and models of hypoinsulinemia produced by agents that deplete the pancreas of insulin secreting ß-cells, using alloxan or streptozotocin (STZ).